Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-003921-25Phase 2Completed
Phase 2 trial of tadalafil in type 2 diabetes mellitus (T2DM), sponsored by Region Västra Götaland. Primary endpoints: Permeability-surface area product for glucose in muscle, Brachioradialis muscle glucose uptake and 1 more. Started May 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-003921-25.